Komrokji R - Search Results

1

Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.

Aguirre LE, Jain A, Ball S, Ali NA, Volpe VO, Tinsley-Vance S, Sallman D, Sweet K, Lancet J, Padron E, Yun S, Kuykendall A, Komrokji R. Aguirre LE, et al. Among authors: komrokji r. Clin Lymphoma Myeloma Leuk. 2024 Jul;24(7):459-467. doi: 10.1016/j.clml.2024.03.001. Epub 2024 Mar 11. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38548563

2

Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature.

Komrokji R, Lancet J, Felgar R, Wang N, Bennett JM. Komrokji R, et al. Leuk Res. 2003 Jun;27(6):561-6. doi: 10.1016/s0145-2126(02)00271-0. Leuk Res. 2003. PMID: 12648517 Review.

3

Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more?

Komrokji RS, Lancet JE, List AF. Komrokji RS, et al. Curr Hematol Malig Rep. 2010 Jan;5(1):9-14. doi: 10.1007/s11899-009-0036-z. Curr Hematol Malig Rep. 2010. PMID: 20425391 Review.

4

Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens.

Price SL, Lancet JE, George TJ, Wetzstein GA, List AF, Ho VQ, Fernandez HF, Pinilla-Ibarz J, Kharfan-Dabaja MA, Komrokji RS. Price SL, et al. Leuk Res. 2011 Mar;35(3):301-4. doi: 10.1016/j.leukres.2010.09.002. Epub 2010 Nov 24. Leuk Res. 2011. PMID: 21109304

5

Biology and treatment of the 5q- syndrome.

Padron E, Komrokji R, List AF. Padron E, et al. Among authors: komrokji r. Expert Rev Hematol. 2011 Feb;4(1):61-9. doi: 10.1586/ehm.11.2. Expert Rev Hematol. 2011. PMID: 21322779 Review.

6

Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.

Bello C, Yu D, Komrokji RS, Zhu W, Wetzstein GA, List AF, Lancet JE. Bello C, et al. Cancer. 2011 Apr 1;117(7):1463-9. doi: 10.1002/cncr.25598. Epub 2010 Nov 8. Cancer. 2011. PMID: 21425147 Free PMC article.

7

Telomere length in myelodysplastic syndromes.

Rollison DE, Epling-Burnette PK, Park JY, Lee JH, Park H, Jonathan K, Cole AL, Painter JS, Guerrier M, Meléndez-Santiago J, Fulp W, Komrokji R, Lancet J, List AF. Rollison DE, et al. Among authors: komrokji r. Leuk Lymphoma. 2011 Aug;52(8):1528-36. doi: 10.3109/10428194.2011.568648. Epub 2011 Jun 3. Leuk Lymphoma. 2011. PMID: 21635204 Free PMC article.

8

Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data.

Komrokji RS, Al Ali NH, Beg MS, Safa MM, Rollison D, Kharfan-Dabaja M, Bello C, Cultrera J, Sokol L, Pinilla-Ibarz J, Sotomayor EM. Komrokji RS, et al. Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):257-60. doi: 10.1016/j.clml.2011.03.012. Epub 2011 Apr 20. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21658652

9

Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.

Mathew RA, Bennett JM, Liu JJ, Komrokji RS, Lancet JE, Naghashpour M, Messina JL, List AF, Moscinski LC, Zhang L. Mathew RA, et al. Leuk Res. 2012 Jan;36(1):72-80. doi: 10.1016/j.leukres.2011.05.003. Epub 2011 Jul 22. Leuk Res. 2012. PMID: 21782240 Review.

10

Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome.

Komrokji RS, Corrales-Yepez M, Al Ali N, Kharfan-Dabaja M, Padron E, Fields T, Lancet JE, List AF. Komrokji RS, et al. Cancer. 2012 May 15;118(10):2659-64. doi: 10.1002/cncr.26567. Epub 2011 Sep 28. Cancer. 2012. PMID: 21956402 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

371 results

Search Page